Astera Labs (NASDAQ:ALAB) Shares Gap Up - Here's What Happened

Key Points

• Shares gapped up: ALAB opened at $172.31 after a $165.19 close and last traded near $178.21 on ~1.54M shares, giving the company a market cap of about $25.77 billion.
• Analyst sentiment is broadly positive: the consensus is a Moderate Buy with an average price target of $187.06 after multiple firms raised ratings and targets (e.g., Morgan Stanley $210, Needham $220).
• Insider selling notable: CEO and COO each sold 90,459 shares at ~$144.69 on Nov 17, insiders have sold ~403,936 shares (~$58.9M) in the last 90 days, while insiders still own 12.5% and institutions hold ~60.5%.

Astera Labs, Inc. (NASDAQ:ALAB - Get Free Report)'s stock price gapped up before the market opened on Tuesday . The stock had previously closed at $165.19, but opened at $172.31. Astera Labs shares last traded at $178.2080, with a volume of 1,541,747 shares.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on ALAB. BNP Paribas started coverage on Astera Labs in a research report on Thursday, November 20th. They issued an "outperform" rating for the company. CICC Research started coverage on Astera Labs in a research note on Friday, August 29th. They issued an "outperform" rating and a $190.00 price objective on the stock. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Astera Labs in a research note on Wednesday, October 8th. Morgan Stanley lifted their target price on Astera Labs from $200.00 to $210.00 and gave the stock an "overweight" rating in a report on Wednesday, November 5th. Finally, Needham & Company LLC boosted their price target on shares of Astera Labs from $205.00 to $220.00 and gave the stock a "buy" rating in a research report on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have given a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $187.06.

Astera Labs Price Performance

The firm has a market capitalization of $25.77 billion, a PE ratio of 138.01, a P/E/G ratio of 2.94 and a beta of 1.52. The firm has a fifty day moving average price of $174.51 and a 200 day moving average price of $149.83.

Insider Activity

In related news, CEO Jitendra Mohan sold 90,459 shares of the company's stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the sale, the chief executive officer owned 2,080,418 shares in the company, valued at approximately $301,015,680.42. This represents a 4.17% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Sanjay Gajendra sold 90,459 shares of the firm's stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71. Following the completion of the transaction, the chief operating officer directly owned 1,599,750 shares of the company's stock, valued at $231,467,827.50. This represents a 5.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 403,936 shares of company stock valued at $58,920,200 over the last ninety days. Corporate insiders own 12.50% of the company's stock.

Institutional Trading of Astera Labs

Hedge funds have recently modified their holdings of the business. Vanguard Group Inc. grew its position in Astera Labs by 14.1% during the third quarter. Vanguard Group Inc. now owns 13,743,141 shares of the company's stock valued at $2,690,907,000 after purchasing an additional 1,693,918 shares in the last quarter. Alliancebernstein L.P. boosted its stake in Astera Labs by 114.2% during the 1st quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company's stock valued at $501,289,000 after purchasing an additional 4,478,741 shares during the period. Atreides Management LP increased its position in Astera Labs by 153.3% during the first quarter. Atreides Management LP now owns 4,652,264 shares of the company's stock worth $277,601,000 after acquiring an additional 2,815,614 shares during the period. State Street Corp raised its position in shares of Astera Labs by 9.1% during the third quarter. State Street Corp now owns 2,339,451 shares of the company's stock valued at $458,065,000 after buying an additional 195,992 shares during the last quarter. Finally, Fred Alger Management LLC lifted its position in shares of Astera Labs by 13.0% in the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company's stock worth $93,087,000 after acquiring an additional 179,638 shares during the period. Hedge funds and other institutional investors own 60.47% of the company's stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.